Sale!

POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies inherited mutations in the POT1 gene, which significantly increases the risk of developing familial melanoma. This comprehensive next-generation sequencing test provides crucial information about your genetic predisposition to cutaneous malignant melanoma, enabling proactive cancer prevention strategies. The test costs $500 USD and is particularly recommended for individuals with a family history of melanoma or multiple atypical moles. By detecting POT1 gene mutations early, patients can implement enhanced surveillance measures and reduce their melanoma risk through targeted prevention approaches. Our genetic counseling services help interpret results and develop personalized risk management plans for optimal health outcomes.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility NGS Genetic DNA Test

Understanding POT1 Gene Melanoma Susceptibility Testing

The POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced diagnostic examination utilizes next-generation sequencing technology to identify specific mutations in the POT1 (Protection of Telomeres 1) gene, which plays a critical role in maintaining chromosomal stability and preventing uncontrolled cell growth.

What Does This Test Measure?

Our comprehensive NGS genetic analysis specifically targets:

  • Complete sequencing of the POT1 gene to identify pathogenic variants
  • Detection of inherited mutations associated with familial melanoma type 10
  • Assessment of telomere protection mechanisms and DNA damage response
  • Identification of specific genetic markers that increase melanoma susceptibility

Who Should Consider POT1 Gene Testing?

This genetic test is particularly recommended for individuals who exhibit:

  • Family history of melanoma in multiple relatives
  • Personal history of multiple primary melanomas
  • Diagnosis of melanoma at a young age (under 40)
  • Presence of numerous atypical moles or dysplastic nevi
  • Family members with confirmed POT1 gene mutations
  • Individuals of European descent with increased melanoma risk

Clinical Indications and Symptoms

Patients experiencing the following should consider genetic testing:

  • Unusual mole development or changes in existing moles
  • Family clustering of skin cancers
  • Multiple primary melanomas in the same individual
  • Early-onset melanoma diagnosis
  • Presence of other cancers in the family suggesting genetic predisposition

Benefits of POT1 Genetic Testing

Undergoing POT1 gene analysis provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before melanoma develops
  • Personalized Prevention: Implement targeted surveillance and prevention strategies
  • Family Planning: Understand inheritance patterns for future generations
  • Reduced Anxiety: Clarify genetic status and provide peace of mind
  • Enhanced Screening: Establish appropriate monitoring schedules based on genetic risk
  • Treatment Guidance: Inform therapeutic decisions if melanoma develops

Understanding Your Test Results

Our comprehensive genetic counseling helps interpret your POT1 test results:

  • Positive Result: Indicates presence of a POT1 gene mutation requiring enhanced surveillance and preventive measures
  • Negative Result: No identified mutation, though continued sun protection remains important
  • Variant of Uncertain Significance: Requires ongoing research and careful clinical correlation
  • Family Implications: Results may impact genetic risk assessment for blood relatives

Test Pricing and Details

Test Feature Details
Test Name POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Understanding of potential psychological impact of results

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified genetic counselors and oncology specialists ensures comprehensive care regardless of your location.

Take Control of Your Genetic Health Today

Don’t wait to understand your melanoma risk profile. Early detection of POT1 gene mutations can significantly impact your long-term health outcomes and provide valuable information for your entire family. Our team of genetic specialists and oncology experts are ready to guide you through the testing process and help develop personalized prevention strategies.

Ready to schedule your POT1 genetic test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online to take the first step toward proactive cancer prevention.